These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18347771)

  • 1. [Value of breast MRI as supplement to mammography and sonography for high risk breast cancer patients].
    Schlossbauer T; Hellerhoff K; Reiser M
    Radiologe; 2008 Apr; 48(4):351-7. PubMed ID: 18347771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the correlation between film mammography and MRI for screening women with increased breast cancer risk.
    Lee JM; Halpern EF; Rafferty EA; Gazelle GS
    Acad Radiol; 2009 Nov; 16(11):1323-8. PubMed ID: 19632865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.
    Granader EJ; Dwamena B; Carlos RC
    Acad Radiol; 2008 Dec; 15(12):1590-5. PubMed ID: 19000876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with imaging and procedural events used to detect breast cancer after screening mammography.
    Carney PA; Abraham LA; Miglioretti DL; Yabroff KR; Sickles EA; Buist DS; Kasales CJ; Geller BM; Rosenberg RD; Dignan MB; Weaver DL; Kerlikowske K;
    AJR Am J Roentgenol; 2007 Feb; 188(2):385-92. PubMed ID: 17242246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
    Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
    Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
    Riedl CC; Luft N; Bernhart C; Weber M; Bernathova M; Tea MK; Rudas M; Singer CF; Helbich TH
    J Clin Oncol; 2015 Apr; 33(10):1128-35. PubMed ID: 25713430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer risk assessment in 64,659 women at a single high-volume mammography clinic.
    Brinton JT; Barke LD; Freivogel ME; Jackson S; O'Donnell CI; Glueck DH
    Acad Radiol; 2012 Jan; 19(1):95-9. PubMed ID: 22054804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer.
    Yeh E; Slanetz P; Kopans DB; Rafferty E; Georgian-Smith D; Moy L; Halpern E; Moore R; Kuter I; Taghian A
    AJR Am J Roentgenol; 2005 Mar; 184(3):868-77. PubMed ID: 15728611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of magnetic resonance imaging in screening women at high risk of breast cancer.
    Warner E
    Top Magn Reson Imaging; 2008 Jun; 19(3):163-9. PubMed ID: 18941396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging: the evolution of breast imaging.
    Heywang-Köbrunner SH; Hacker A; Sedlacek S
    Breast; 2013 Aug; 22 Suppl 2():S77-82. PubMed ID: 24074797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of current evidence-based clinical applications for breast magnetic resonance imaging.
    DeMartini W; Lehman C
    Top Magn Reson Imaging; 2008 Jun; 19(3):143-50. PubMed ID: 18941394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study.
    Narayan AK; Visvanathan K; Harvey SC
    Breast Cancer Res Treat; 2016 Aug; 158(3):583-9. PubMed ID: 27444927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
    Sardanelli F; Podo F; Santoro F; Manoukian S; Bergonzi S; Trecate G; Vergnaghi D; Federico M; Cortesi L; Corcione S; Morassut S; Di Maggio C; Cilotti A; Martincich L; Calabrese M; Zuiani C; Preda L; Bonanni B; Carbonaro LA; Contegiacomo A; Panizza P; Di Cesare E; Savarese A; Crecco M; Turchetti D; Tonutti M; Belli P; Maschio AD;
    Invest Radiol; 2011 Feb; 46(2):94-105. PubMed ID: 21139507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy--monitoring: clinical examination, ultrasound, mammography, MRI, elastography: only one, only few or all?
    Schulz-Wendtland R
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S147-8. PubMed ID: 23083568
    [No Abstract]   [Full Text] [Related]  

  • 15. Time-Related Changes in Yield and Harms of Screening Breast Magnetic Resonance Imaging.
    Pederson HJ; O'Rourke C; Lyons J; Patrick RJ; Crowe JP; Grobmyer SR
    Clin Breast Cancer; 2015 Oct; 15(5):348-52. PubMed ID: 25749071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The positive predictive value for diagnosis of breast cancer full-field digital mammography versus film-screen mammography in the diagnostic mammographic population.
    Seo BK; Pisano ED; Kuzmiak CM; Koomen M; Pavic D; McLelland R; Lee Y; Cole EB; Mattingly D; Lee J
    Acad Radiol; 2006 Oct; 13(10):1229-35. PubMed ID: 16979072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer.
    Lord SJ; Lei W; Craft P; Cawson JN; Morris I; Walleser S; Griffiths A; Parker S; Houssami N
    Eur J Cancer; 2007 Sep; 43(13):1905-17. PubMed ID: 17681781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detectability and clinicohistological characteristics of small (≤1 cm) invasive breast cancer.
    Yoo EY; Shin JH; Ko EY; Han BK; Cho EY; Nam SJ; Hahn SY; Ko ES
    Eur J Radiol; 2013 Oct; 82(10):e556-61. PubMed ID: 23830035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk.
    Miles R; Wan F; Onega TL; Lenderink-Carpenter A; O'Meara ES; Zhu W; Henderson LM; Haas JS; Hill DA; Tosteson ANA; Wernli KJ; Alford-Teaster J; Lee JM; Lehman CD; Lee CI
    J Womens Health (Larchmt); 2018 Jun; 27(6):748-754. PubMed ID: 29341851
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.